𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutational Analysis of CDKN2 (CDK4I/MTS1) Gene in Tissues and Cell Lines of Human Prostate Cancer

✍ Scribed by Komiya, Akira ;Suzuki, Hiroyoshi ;Aida, Sara ;Yatani, Ryuichi ;Shimazaki, Jun

Book ID
108580989
Publisher
Wiley (Blackwell Publishing)
Year
1995
Tongue
English
Weight
229 KB
Volume
86
Category
Article
ISSN
0910-5050

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Deletional, mutational, and methylation
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer
✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Expression and mutational analysis of th
Expression and mutational analysis of theMADR2/smad2 gene in human prostate cancer
✍ Latil, Alain; Pesche, Sandrine; ValοΏ½ri, Antoine; Fournier, Georges; Cussenot, Ol πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 2 views

BACKGROUND. Loss of heterozygosity (LOH) on chromosome arm 18q is common in sporadic prostate cancer and may be involved in cancer development through inactivation of tumor-suppressor genes (TSG). Recent identification, at 18q21.1, of MADR2/Smad2, a key component in transforming growth factor ␀ (TGF

Mutational analysis of the TrkA gene in
Mutational analysis of the TrkA gene in prostate cancer
✍ George, Daniel J.; Suzuki, Hiroyoshi; Bova, G. Steven; Isaacs, John T. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 629 KB

## Background: Trka, the high affinity, tyrosine kinase receptor for nerve growth factor (ngf) has been implicated as an oncogene in several neoplasms. in prostate cancer, inhibitors of the ngf/trka signal pathway results in tumor growth inhibition. in contrast, inhibition of this trk pathway in th